| Year |
Citation |
Score |
| 2022 |
Asadi M, Devarajan K, Ebrahimi N, Soofi ES, Spirko-Burns L. Elaboration Models with Symmetric Information Divergence. International Statistical Review = Revue Internationale De Statistique. 90: 499-524. PMID 37214632 DOI: 10.1111/insr.12499 |
0.451 |
|
| 2020 |
Spirko-Burns L, Devarajan K. Supervised dimension reduction for large-scale "omics" data with censored survival outcomes under possible non-proportional hazards. Ieee/Acm Transactions On Computational Biology and Bioinformatics. PMID 31940547 DOI: 10.1109/Tcbb.2020.2965934 |
0.322 |
|
| 2020 |
Rengan AK, Dotan E, Devarajan K, Vijayvergia N. Genomic associations in metastatic pancreatic cancer (mPC). Journal of Clinical Oncology. 38: 765-765. DOI: 10.1200/Jco.2020.38.4_Suppl.765 |
0.323 |
|
| 2020 |
Winn JS, Hasse Z, Pei J, Slifker M, Arisi-Fernandez SM, Talarchek JN, Obeid E, Devarajan K, Wu H, Gong Y, Cristofanilli M, Alpaugh RK, Fernandez SV. Abstract P5-03-11: Germline and somatic variants in patients with inflammatory breast cancer (IBC) detected using cell-free DNA Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P5-03-11 |
0.327 |
|
| 2019 |
Mancuso P, Tricarico R, Bhattacharjee V, Cosentino L, Kadariya Y, Jelinek J, Nicolas E, Einarson M, Beeharry N, Devarajan K, Katz RA, Dorjsuren DG, Sun H, Simeonov A, Giordano A, et al. Thymine DNA glycosylase as a novel target for melanoma. Oncogene. PMID 30674989 DOI: 10.1038/S41388-018-0640-2 |
0.315 |
|
| 2019 |
O'Brien SB, Mutabdzic D, Handorf EA, Devarajan K, Reddy SS, Sigurdson ER, Denlinger CS, Meyer JE, Farma JM. Stage II and III rectal adenocarcinoma outcomes related to lymphovascular invasion. Journal of Clinical Oncology. 37: 698-698. DOI: 10.1200/Jco.2019.37.4_Suppl.698 |
0.31 |
|
| 2018 |
Kozinova M, Joshi S, Devarajan K, Zook P, D'Souza JW, Farma JM, Esnaola N, Foroughi R, Yu Y, Schwartz B, Hall T, Mehren Mv, Rink LA. Abstract 4808: Combinations of imatinib mesylate with AKT inhibitor (miransertib, ARQ 751) or FGFR inhibitor (derazantinib) show synergy in GIST cell lines and preclinical models Cancer Research. 78: 4808-4808. DOI: 10.1158/1538-7445.Am2018-4808 |
0.31 |
|
| 2018 |
Ghatalia P, Devarajan K, Gordetsky J, Dulaimi E, Bae S, Naik G, Sonpavde G, Plimack E. Abstract 3141: Immune gene expression and prognosis in localized clear cell (cc) renal cell carcinoma (RCC) Cancer Research. 78: 3141-3141. DOI: 10.1158/1538-7445.Am2018-3141 |
0.315 |
|
| 2018 |
Tricarico R, Mancuso P, Bhattacharjee V, Cosentino L, Nicolas E, Einarson M, Beeharry N, Devarajan K, Katz R, Dorjsuren DG, Simeonov A, Kadariya Y, Davidson G, Testa JR, Davidson I, et al. Abstract 1940: Thymine DNA glycosylase (TDG) as a novel target for melanoma Cancer Research. 78: 1940-1940. DOI: 10.1158/1538-7445.Am2018-1940 |
0.318 |
|
| 2017 |
Jiang W, Dulaimi E, Devarajan K, Parsons T, Wang Q, O'Neill R, Solomides C, Peiper SC, Testa JR, Uzzo R, Yang H. Intratumoral heterogeneity analysis reveals hidden associations between protein expression losses and patient survival in clear cell renal cell carcinoma. Oncotarget. PMID 28445125 DOI: 10.18632/Oncotarget.16965 |
0.31 |
|
| 2017 |
Franco-Barraza J, Francescone R, Luong T, Shah N, Madhani R, Cukierman G, Dulaimi E, Devarajan K, Egleston BL, Nicolas E, Katherine Alpaugh R, Malik R, Uzzo RG, Hoffman JP, Golemis EA, et al. Matrix-regulated integrin αvβ5 maintains α5β1-dependent desmoplastic traits prognostic of neoplastic recurrence. Elife. 6. PMID 28139197 DOI: 10.7554/Elife.20600 |
0.303 |
|
| 2016 |
Peri S, Caretti E, Tricarico R, Devarajan K, Cheung M, Sementino E, Menges CW, Nicolas E, Vanderveer LA, Howard S, Conrad P, Crowell JA, Campbell KS, Ross EA, Godwin AK, et al. Haploinsufficiency in tumor predisposition syndromes: altered genomic transcription in morphologically normal cells heterozygous for VHL or TSC mutation. Oncotarget. PMID 27682873 DOI: 10.18632/Oncotarget.12192 |
0.333 |
|
| 2015 |
Devarajan K, Ebrahimi N, Soofi E. A Hybrid Algorithm for Non-negative Matrix Factorization Based on Symmetric Information Divergence. Proceedings. Ieee International Conference On Bioinformatics and Biomedicine. 2015: 1658-1664. PMID 28868206 DOI: 10.1109/BIBM.2015.7359924 |
0.443 |
|
| 2015 |
Murphy CT, Devarajan K, Wang LS, Mehra R, Ridge JA, Fundakowski C, Galloway TJ. Pre-treatment tumor-specific growth rate as a temporal biomarker that predicts treatment failure and improves risk stratification for oropharyngeal cancer. Oral Oncology. PMID 26410020 DOI: 10.1016/J.Oraloncology.2015.09.001 |
0.302 |
|
| 2015 |
Vijayvergia N, Dotan E, Devarajan K, Hatahet K, Rahman F, Ricco J, Lewis B, Gupta S, Cohen SJ. Patterns of care and outcomes of older versus younger patients with metastatic pancreatic cancer: A Fox Chase Cancer Center experience. Journal of Geriatric Oncology. PMID 26296909 DOI: 10.1016/J.Jgo.2015.08.001 |
0.32 |
|
| 2015 |
Devarajan K, Wang G, Ebrahimi N. A unified statistical approach to non-negative matrix factorization and probabilistic latent semantic indexing. Machine Learning. 99: 137-163. PMID 25821345 DOI: 10.1007/S10994-014-5470-Z |
0.512 |
|
| 2015 |
Fink LS, Beatty A, Devarajan K, Peri S, Peterson JR. Pharmacological profiling of kinase dependency in cell lines across triple-negative breast cancer subtypes. Molecular Cancer Therapeutics. 14: 298-306. PMID 25344583 DOI: 10.1158/1535-7163.Mct-14-0529 |
0.308 |
|
| 2015 |
Devarajan K, Ebrahimi N, Soofi E. A hybrid algorithm for non-negative matrix factorization based on symmetric information divergence Proceedings - 2015 Ieee International Conference On Bioinformatics and Biomedicine, Bibm 2015. 1658-1664. DOI: 10.1109/BIBM.2015.7359924 |
0.443 |
|
| 2014 |
Pape-Zambito D, Jiang Z, Wu H, Devarajan K, Slater CM, Cai KQ, Patchefsky A, Daly MB, Chen X. Identifying a highly-aggressive DCIS subgroup by studying intra-individual DCIS heterogeneity among invasive breast cancer patients. Plos One. 9: e100488. PMID 24978026 DOI: 10.1371/Journal.Pone.0100488 |
0.316 |
|
| 2014 |
Ragin C, Liu J, Blackman E, Roach V, Devarajan K, Ashing KT, Gathere S, Taioli E. Abstract C93: Head and neck cancer trends in Trinidad and Tobago Cancer Epidemiology, Biomarkers & Prevention. 23. DOI: 10.1158/1538-7755.Disp13-C93 |
0.346 |
|
| 2014 |
Jiang Z, Pape-Zambito D, Devarajan K, Wu H, Slater C, Dolinsky L, Daly M, Chen X. Abstract 4991: Identifying a highly-aggressive DCIS subgroup by studying intra-individual DCIS heterogeneity among invasive breast cancer patients Cancer Research. 74: 4991-4991. DOI: 10.1158/1538-7445.Am2014-4991 |
0.345 |
|
| 2014 |
Gupta V, Franco-Barraza J, Shah N, Dulaimi E, Zhou Y, Devarajan K, Cai KQ, Alpaugh KR, Uzzo RG, Cukierman E. Abstract 137: Tumor-associated ECM induces renal cell carcinoma tumorigenic responses via α6β1-integrin regulation of ITPKA Cancer Research. 74: 137-137. DOI: 10.1158/1538-7445.Am2014-137 |
0.333 |
|
| 2013 |
Devarajan K, Ebrahimi N. On penalized likelihood estimation for a non-proportional hazards regression model. Statistics & Probability Letters. 83: 1703-1710. PMID 24791034 DOI: 10.1016/J.Spl.2013.03.007 |
0.499 |
|
| 2013 |
Fernandez SV, Robertson FM, Pei J, Aburto-Chumpitaz L, Mu Z, Chu K, Alpaugh RK, Huang Y, Cao Y, Ye Z, Cai KQ, Boley KM, Klein-Szanto AJ, Devarajan K, Addya S, et al. Inflammatory breast cancer (IBC): clues for targeted therapies. Breast Cancer Research and Treatment. 140: 23-33. PMID 23784380 DOI: 10.1007/S10549-013-2600-4 |
0.314 |
|
| 2013 |
Fink LS, Beatty A, Devarajan K, Peri S, Peterson JR. Abstract 4370: Protein kinase inhibitor screening uncovers differential kinase dependencies in triple negative breast cancer (TNBC). Cancer Research. 73: 4370-4370. DOI: 10.1158/1538-7445.Am2013-4370 |
0.325 |
|
| 2013 |
Rink LA, Hensley H, Devarajan K, Johnson JR, Piwinica-Worms D, Godwin AK, Mehren Mv. Abstract 3927: Evaluating new therapies in Gastrointestinal Stromal Tumor using in vivo molecular optical imaging. Cancer Research. 73: 3927-3927. DOI: 10.1158/1538-7445.Am2013-3927 |
0.31 |
|
| 2013 |
Pape-Zambito D, Jiang Z, Wu H, Devarajan K, Slater CM, Cai KQ, Patchefsky A, Daly MB, Chen X. Abstract 3653: Intra-individual heterogeneity of DCIS lesions in patients concurrently diagnosed with invasive ductal carcinoma . Cancer Research. 73: 3653-3653. DOI: 10.1158/1538-7445.Am2013-3653 |
0.315 |
|
| 2013 |
Chang W, Ferrara C, Mosier S, Cooper H, Devarajan K, Hensley H, Li T, Clapper M. Abstract 195: Effect of sulindac and/or atorvastatin on colorectal adenomas in the Apc+/Min-FCCCmouse model varies depending on the presence or absence of adenomas at the time of drug initiation. Cancer Research. 73: 195-195. DOI: 10.1158/1538-7445.Am2013-195 |
0.302 |
|
| 2013 |
Jiang Z, Zhou Y, Devarajan K, Slater CM, Daly MB, Chen X. Abstract 1833: Identification of abnormally expressed lincRNAs in breast cancer using high-density SNP arrays. Cancer Research. 73: 1833-1833. DOI: 10.1158/1538-7445.Am2013-1833 |
0.342 |
|
| 2013 |
Vanderveer L, Paramasivam S, Williams K, Cooper H, Devarajan K, Peri S, Zhou Y, Henik L, Chang W, Lubet R, Clapper M. Abstract 182: Differential response of epithelial cells from colorectal adenomas and adjacent nonneoplastic colonic mucosa to aspirin and atorvastatin in Apc+/Min-FCCCmice. Cancer Research. 73: 182-182. DOI: 10.1158/1538-7445.Am2013-182 |
0.321 |
|
| 2012 |
Dotan E, Nicolas E, Devarajan K, Beck RJ, Cohen SJ. A pilot study evaluating peripheral blood lymphocyte telomere length in elderly versus young patients with colorectal cancer (CRC). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 512. PMID 27983408 DOI: 10.1200/Jco.2012.30.4_Suppl.512 |
0.305 |
|
| 2012 |
Chen KT, Singla S, Papavasiliou P, Devarajan K, Hoffman JP. Revisiting the prognostic significance of positive peritoneal cytology in pancreatic cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 177. PMID 27982820 DOI: 10.1200/Jco.2012.30.4_Suppl.177 |
0.324 |
|
| 2012 |
Buyyounouski MK, Zaorsky NG, Li T, Devarajan K, Horwitz EM. Assessment of the American Joint Committee on Cancer (6th and 7th editions) for clinically localized prostate cancer and comparison to the National Comprehensive Cancer Network risk stratification method. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 23. PMID 27967856 DOI: 10.1200/Jco.2012.30.5_Suppl.23 |
0.302 |
|
| 2012 |
Jiang Z, Zhou Y, Devarajan K, Slater CM, Daly MB, Chen X. Identifying putative breast cancer-associated long intergenic non-coding RNA loci by high density SNP array analysis. Frontiers in Genetics. 3: 299. PMID 23267367 DOI: 10.3389/Fgene.2012.00299 |
0.311 |
|
| 2012 |
Gao C, Devarajan K, Zhou Y, Slater CM, Daly MB, Chen X. Identifying breast cancer risk loci by global differential allele-specific expression (DASE) analysis in mammary epithelial transcriptome. Bmc Genomics. 13: 570. PMID 23107584 DOI: 10.1186/1471-2164-13-570 |
0.316 |
|
| 2012 |
Zaorsky NG, Li T, Devarajan K, Horwitz EM, Buyyounouski MK. Assessment of the American Joint Committee on Cancer staging (sixth and seventh editions) for clinically localized prostate cancer treated with external beam radiotherapy and comparison with the National Comprehensive Cancer Network risk-stratification method. Cancer. 118: 5535-43. PMID 22544661 DOI: 10.1002/Cncr.27597 |
0.312 |
|
| 2012 |
Gao C, Slater CM, Devarajan K, Zhou Y, Daly MB, Chen X. Abstract LB-407: Global differential allele-specific expression (DASE) analysis in mammary epithelial transcriptome Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-407 |
0.343 |
|
| 2012 |
Shatalova EG, Mosier SL, Devarajan K, Clapper ML. Abstract 1602: Time-to-recurrence is decreased in head and neck cancer patients with a common cytochrome P450 1B1 variant (N453S); epidemiological andin vitrofindings Cancer Research. 72: 1602-1602. DOI: 10.1158/1538-7445.Am2012-1602 |
0.314 |
|
| 2011 |
Gupta V, Bassi DE, Simons JD, Devarajan K, Al-Saleem T, Uzzo RG, Cukierman E. Elevated expression of stromal palladin predicts poor clinical outcome in renal cell carcinoma. Plos One. 6: e21494. PMID 21738681 DOI: 10.1371/Journal.Pone.0021494 |
0.311 |
|
| 2011 |
Sasaroli D, Gimotty PA, Pathak HB, Hammond R, Kougioumtzidou E, Katsaros D, Buckanovich R, Devarajan K, Sandaltzopoulos R, Godwin AK, Scholler N, Coukos G. Novel surface targets and serum biomarkers from the ovarian cancer vasculature. Cancer Biology & Therapy. 12: 169-80. PMID 21617380 DOI: 10.4161/Cbt.12.3.16260 |
0.317 |
|
| 2011 |
Devarajan K, Ebrahimi N. A semi-parametric generalization of the Cox proportional hazards regression model: Inference and Applications. Computational Statistics & Data Analysis. 55: 667-676. PMID 21076652 DOI: 10.1016/J.Csda.2010.06.010 |
0.505 |
|
| 2011 |
Makhlin I, Zhang J, Long CJ, Devarajan K, Zhou Y, Klein-Szanto AJ, Huang M, Chernoff J, Boorjian SA. The mTOR pathway affects proliferation and chemosensitivity of urothelial carcinoma cells and is upregulated in a subset of human bladder cancers. Bju International. 108: E84-90. PMID 21050361 DOI: 10.1111/J.1464-410X.2010.09844.X |
0.319 |
|
| 2011 |
Slater CM, Devarajan K, Zhou Y, Chen X. Abstract LB-275: Identifying novel candidate breast cancer candidate loci by genome-wide allele-specific expression analysis Cancer Research. 71. DOI: 10.1158/1538-7445.Am2011-Lb-275 |
0.337 |
|
| 2010 |
Devarajan K, Zhou Y, Chachra N, Ebrahimi N. A supervised approach for predicting patient survival with gene expression data. Proceedings / Annual Ieee International Symposium On Bioinformatics and Bioengineering (Bibe). Ieee International Symposium On Bioinformatics and Bioengineering. 2010: 26-31. PMID 20865131 DOI: 10.1109/BIBE.2010.14 |
0.5 |
|
| 2010 |
Bellacosa A, Godwin AK, Peri S, Devarajan K, Caretti E, Vanderveer L, Bove B, Slater C, Zhou Y, Daly M, Howard S, Campbell KS, Nicolas E, Yeung AT, Clapper ML, et al. Altered gene expression in morphologically normal epithelial cells from heterozygous carriers of BRCA1 or BRCA2 mutations. Cancer Prevention Research (Philadelphia, Pa.). 3: 48-61. PMID 20051372 DOI: 10.1158/1940-6207.Capr-09-0078 |
0.34 |
|
| 2010 |
Chen X, Schaeffer A, Devarajan K, Liao C, Zhou Y, Slater C, Vanderveer L, Conroy J, Godwin A. Abstract P3-08-03: Defects in BRCA1 Contribute to Global Differential Allele-Specific Expression Cancer Research. 70. DOI: 10.1158/0008-5472.Sabcs10-P3-08-03 |
0.318 |
|
| 2010 |
Boorjian S, Zhang J, Makhlin I, Long C, Devarajan K, Zhou Y, Huang M, Chernoff J. 775 THE MTOR PATHWAY IMPACTS PROLIFERATION AND CHEMOSENSITIVITY OF UROTHELIAL CARCINOMA CELLS IN VITRO AND IS HIGHLY EXPRESSED IN A SUBSET OF HUMAN BLADDER CANCERS Journal of Urology. 183. DOI: 10.1016/J.Juro.2010.02.1424 |
0.31 |
|
| 2009 |
Devarajan K, Ebrahimi N. Testing for Covariate Effect in the Cox Proportional Hazards Regression Model. Communications in Statistics: Theory and Methods. 38: 2333-2347. PMID 20054448 DOI: 10.1080/03610920802536958 |
0.506 |
|
| 2008 |
Devarajan K, Ebrahimi N. Class discovery via nonnegative matrix factorization American Journal of Mathematical and Management Sciences. 28: 457-467. DOI: 10.1080/01966324.2008.10737738 |
0.532 |
|
| 1998 |
Devarajan K, Ebrahimi N. A nonparametric approach to accelerated life testing under multiple stresses Naval Research Logistics. 45: 628-644. DOI: 10.1002/(Sici)1520-6750(199809)45:6<629::Aid-Nav6>3.0.Co;2-4 |
0.43 |
|
| Show low-probability matches. |